Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combination treatment of prostate cancer
with IMC-A12 (an antibody which blocks insulin-like growth factor receptor activity) with
hormonal therapy (testosterone lowering) before prostatectomy, will be more effective than
prior results with hormonal therapy alone.